Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
IBS is a chronic disorder characterized by abdominal pain or discomfort associated with altered bowel function for at least three months, according to the Rome III criteria. Patients often experience relapse of symptoms over time.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Irritable Bowel Syndrome (IBS) Therapeutics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Irritable Bowel Syndrome (IBS) Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Irritable Bowel Syndrome (IBS) Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
GlaxoSmithKline
Abbott Laboratories
Sucampo Pharmaceuticals
Ardelyx
Synergy Pharmaceuticals
Valeant Pharmaceuticals International
Astellas Pharma
Ironwood Pharmaceuticals
Novartis
By Type:
Blautix (Strain)
Bekinda (IBS-D)
SYN-010
Tenapanor
By End-User:
Hospital
Research
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Irritable Bowel Syndrome (IBS) Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 USA Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate of Blautix (Strain) from 2016 to 2027
-
1.3.2 USA Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate of Bekinda (IBS-D) from 2016 to 2027
-
1.3.3 USA Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate of SYN-010 from 2016 to 2027
-
1.3.4 USA Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate of Tenapanor from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 USA Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate of Research from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Irritable Bowel Syndrome (IBS) Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Irritable Bowel Syndrome (IBS) Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of Blautix (Strain)
-
3.4.2 Market Size and Growth Rate of Bekinda (IBS-D)
-
3.4.3 Market Size and Growth Rate of SYN-010
-
3.4.4 Market Size and Growth Rate of Tenapanor
4 Segmentation of Irritable Bowel Syndrome (IBS) Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Irritable Bowel Syndrome (IBS) Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Irritable Bowel Syndrome (IBS) Therapeutics in Hospital
-
4.4.2 Market Size and Growth Rate of Irritable Bowel Syndrome (IBS) Therapeutics in Research
5 Market Analysis by Regions
-
5.1 USA Irritable Bowel Syndrome (IBS) Therapeutics Production Analysis by Regions
-
5.2 USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Irritable Bowel Syndrome (IBS) Therapeutics Landscape Analysis
-
6.1 West USA Irritable Bowel Syndrome (IBS) Therapeutics Landscape Analysis by Major Types
-
6.2 West USA Irritable Bowel Syndrome (IBS) Therapeutics Landscape Analysis by Major End-Users
7 South USA Irritable Bowel Syndrome (IBS) Therapeutics Landscape Analysis
-
7.1 South USA Irritable Bowel Syndrome (IBS) Therapeutics Landscape Analysis by Major Types
-
7.2 South USA Irritable Bowel Syndrome (IBS) Therapeutics Landscape Analysis by Major End-Users
8 Middle West USA Irritable Bowel Syndrome (IBS) Therapeutics Landscape Analysis
-
8.1 Middle West USA Irritable Bowel Syndrome (IBS) Therapeutics Landscape Analysis by Major Types
-
8.2 Middle West USA Irritable Bowel Syndrome (IBS) Therapeutics Landscape Analysis by Major End-Users
9 Northeast USA Irritable Bowel Syndrome (IBS) Therapeutics Landscape Analysis
-
9.1 Northeast USA Irritable Bowel Syndrome (IBS) Therapeutics Landscape Analysis by Major Types
-
9.2 Northeast USA Irritable Bowel Syndrome (IBS) Therapeutics Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 GlaxoSmithKline
-
10.1.1 GlaxoSmithKline Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Abbott Laboratories
-
10.2.1 Abbott Laboratories Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Sucampo Pharmaceuticals
-
10.3.1 Sucampo Pharmaceuticals Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Ardelyx
-
10.4.1 Ardelyx Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Synergy Pharmaceuticals
-
10.5.1 Synergy Pharmaceuticals Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Valeant Pharmaceuticals International
-
10.6.1 Valeant Pharmaceuticals International Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Astellas Pharma
-
10.7.1 Astellas Pharma Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Ironwood Pharmaceuticals
-
10.8.1 Ironwood Pharmaceuticals Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Novartis
-
10.9.1 Novartis Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate of Blautix (Strain) from 2016 to 2027
-
Figure USA Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate of Bekinda (IBS-D) from 2016 to 2027
-
Figure USA Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate of SYN-010 from 2016 to 2027
-
Figure USA Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate of Tenapanor from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure USA Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate of Research from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Irritable Bowel Syndrome (IBS) Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Irritable Bowel Syndrome (IBS) Therapeutics
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Irritable Bowel Syndrome (IBS) Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of Irritable Bowel Syndrome (IBS) Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Blautix (Strain)
-
Figure Market Size and Growth Rate of Bekinda (IBS-D)
-
Figure Market Size and Growth Rate of SYN-010
-
Figure Market Size and Growth Rate of Tenapanor
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Irritable Bowel Syndrome (IBS) Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Irritable Bowel Syndrome (IBS) Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Research
-
Table USA Irritable Bowel Syndrome (IBS) Therapeutics Production by Regions
-
Table USA Irritable Bowel Syndrome (IBS) Therapeutics Production Share by Regions
-
Figure USA Irritable Bowel Syndrome (IBS) Therapeutics Production Share by Regions in 2016
-
Figure USA Irritable Bowel Syndrome (IBS) Therapeutics Production Share by Regions in 2021
-
Figure USA Irritable Bowel Syndrome (IBS) Therapeutics Production Share by Regions in 2027
-
Table USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption by Regions
-
Table USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Regions
-
Figure USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Regions in 2016
-
Figure USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Regions in 2021
-
Figure USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Regions in 2027
-
Table West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption by Types from 2016 to 2027
-
Table West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Types in 2016
-
Figure West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Types in 2021
-
Figure West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Types in 2027
-
Table West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption by End-Users from 2016 to 2027
-
Table West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by End-Users in 2016
-
Figure West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by End-Users in 2021
-
Figure West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by End-Users in 2027
-
Table South USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption by Types from 2016 to 2027
-
Table South USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Types in 2016
-
Figure South USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Types in 2021
-
Figure South USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Types in 2027
-
Table South USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by End-Users in 2016
-
Figure South USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by End-Users in 2021
-
Figure South USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by End-Users in 2027
-
Table Middle West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption by Types from 2016 to 2027
-
Table Middle West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Types in 2016
-
Figure Middle West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Types in 2021
-
Figure Middle West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Types in 2027
-
Table Middle West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by End-Users in 2016
-
Figure Middle West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by End-Users in 2021
-
Figure Middle West USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Types in 2016
-
Figure Northeast USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Types in 2021
-
Figure Northeast USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by Types in 2027
-
Table Northeast USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast USA Irritable Bowel Syndrome (IBS) Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Abbott Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories
-
Figure Sales and Growth Rate Analysis of Abbott Laboratories
-
Figure Revenue and Market Share Analysis of Abbott Laboratories
-
Table Product and Service Introduction of Abbott Laboratories
-
Table Company Profile and Development Status of Sucampo Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sucampo Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Sucampo Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Sucampo Pharmaceuticals
-
Table Product and Service Introduction of Sucampo Pharmaceuticals
-
Table Company Profile and Development Status of Ardelyx
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ardelyx
-
Figure Sales and Growth Rate Analysis of Ardelyx
-
Figure Revenue and Market Share Analysis of Ardelyx
-
Table Product and Service Introduction of Ardelyx
-
Table Company Profile and Development Status of Synergy Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synergy Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Synergy Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Synergy Pharmaceuticals
-
Table Product and Service Introduction of Synergy Pharmaceuticals
-
Table Company Profile and Development Status of Valeant Pharmaceuticals International
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals International
-
Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals International
-
Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals International
-
Table Product and Service Introduction of Valeant Pharmaceuticals International
-
Table Company Profile and Development Status of Astellas Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma
-
Figure Sales and Growth Rate Analysis of Astellas Pharma
-
Figure Revenue and Market Share Analysis of Astellas Pharma
-
Table Product and Service Introduction of Astellas Pharma
-
Table Company Profile and Development Status of Ironwood Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ironwood Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Ironwood Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Ironwood Pharmaceuticals
-
Table Product and Service Introduction of Ironwood Pharmaceuticals
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
